An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to new research. Scientists say the vaccine is ...

Researchers at the University of Texas Medical Branch in Galveston have built an artificial intelligence pipeline that sifts ...

A team of scientists at The University of Texas Medical Branch (UTMB), led by Nikos Vasilakis, Ph.D., and Peter McCaffrey, MD ...

The chikungunya virus virus-like particle (CHIKV VLP) vaccine achieved 100% seroconversion in adults who had previously received alphavirus vaccines and alphavirus vaccine–naive control individuals, ...

Griffith University and an international team of researchers have moved a step closer to identifying a broad spectrum treatment for the dreaded arthritogenic alphavirus infections. The threat of a ...

Many alphaviruses are medically relevant; chikungunya virus, for example, is an emerging human pathogen responsible for major recent epidemics 3. There are currently no treatments for alphavirus ...

GAITHERSBURG, Md., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced results from a Phase 2 study evaluating the safety and immunogenicity of the company’s adjuvanted ...

Do a person's antibodies work to block the COVID-19 virus from infecting one's system? Are these antibodies also capable of blocking emerging variants such as the omicrons? These are the questions ...

Research conducted by Griffith University and Melbourne-based company Paradigm Biopharmaceuticals Limited (ASX: PAR) has uncovered a potential new therapeutic treatment for the global battle against ...

DURHAM, N.C. – An experimental vaccine based on a virus that causes encephalitis in the wild appears to block tumor growth in some cases of advanced cancer, according to researchers at Duke University ...